Beijing (1)

Cancer, Solid Tumor (1)

Active, not recruiting (1)

phase 1 (1)

Innovent Biologics (Suzhou) Co. Ltd. (1)

ibi308 (1)

ibi308\cisplatin\gemcitabine (1)

ibi308\cisplatinum\pemetrexed (1)

ibi308\etoposide\cisplatin (1)

ibi308\irinotecan\5-fu (1)

ibi308\oxaliplatin\capecitabine (1)

drug (1)

Industry (1)

Interventional (1)

cancer, solid tumor

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Feb 18, 2021